KYG2929M1087
KYG2929M1087
DUALITYBIO-B
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.851.735.000 | 1.941.257.000 | 4.6% |
| Cost of Revenue | 1.262.642.000 | 1.156.590.000 | 9.2% |
| Gross Profit | 589.093.000 | 784.667.000 | 24.9% |
| 1.044.094.000 | 988.080.000 | 5.7% | |
| Operating Income | -455.001.000 | -203.413.000 | 123.7% |
| Pretax Income | -2.594.827.000 | -1.014.546.000 | 155.8% |
| Net Income Common Stockholders | -2.594.827.000 | -1.050.434.000 | 147.0% |
| -- | -- | -- | |
| -- | -- | -- |